FDA Inspection 1087864 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 1073001

The FDA completed an inspection of American Red Cross Blood Services on March 11, 2019 in Birmingham, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 11, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Birmingham, AL (United States)